Viscosupplementation Market

The report "Viscosupplementation Market by Product (Single, Three, Five Injection), Application (knee, hip osteoarthritis), Source (animal, non-animal), End-user (Hospitals, Orthopedic Clinics/ASCs), Region (northamerica, Asia Pacific, Europe) - Forecast to 2027", size is projected to reach USD XX million by 2027 from USD XX million in 2022, at a CAGR of XX% during the forecast period.

View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/viscosupplementation-market-72571451.html

Market is driven by factors such as increasing global prevalence of osteoarthritis, rising older population, and growing sports injuries. On the other hand, higher cost of products is expected to limit market growth to a certain extent in the coming years. Upsurge in the number of older people amongst global population is anticipated to drive the viscosupplementation market growth. However, availability of alternate treatment for knee osteoarthritis is anticipated to hinder market development.

“The single injection accounted for the largest market share in the Viscosupplementation market, product, during the forecast period”

The Viscosupplementation market is segmented into single injection, three injection, and five injection. In 2021, single injection accounted for a sizable market share and is expected to increase significantly between 2021 and 2027. The increasing obesity in Russia coupled with rising geriatric population is leading to increase in knee osteoarthritis prevalence. In 2021, the World Bank showed the increase of geriatric population in US from 12.79%  in 2010 to 17% in 2021, which will lead to knee osteoarthritis prevalence and will drive the viscosupplementation market.

“Knee osteosrthritis segment accounted for the largest market share in the viscosupplementation market, by application, during the forecast period”

Based on application, the viscosupplementation market is segmented into knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, and other applications. The knee osteoarthritis segment accounted for the largest market share in 2021. This can be attributed to the rising in prevalence of knee osteoarthritis coupled with surge in geriatric population.

“Non-animal source segment accounted for the highest CAGR”

Based on source, the viscosupplementation market is segmented into animal source and non-animal source. The non-animal source segment accounted for the highest CAGR during the forecast period. This can be attributed due to lesser side effects, and greater effectiveness & safety.

“Orthopedic clinics/ASCs segment accounted for the largest market share”

Based on end user, the viscosupplementation market is segmented into hospitals, orthopedic clinics/ambulatory surgical centers (ASCs), retail pharmacies, and online pharmacies. The orthopedic clinics/ambulatory surgical centers (ASCs) segment accounted for the largest market share in 2021. This can be attributed due to growing surgeries in outpatient clinics/ASCs that offers surgery centers and focuses on same day surgical care.

“Europe region accounted for the highest CAGR”

The global viscosupplementation market is divided into five regions: North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. According to the regional analysis, the Asia-Pacific region is likely to retain a significant market share in 2021 and the future. The Asia-Pacific viscosupplementation market is being propelled by the growing number of geriatric population due to which the prevalence of osteoarthritis will increase. Europe, on the other hand, will experience significant growth in the coming years due to increase in investments by market players. The major players operating in this market are  Sanofi (France), Anika Therapeutics, Inc. (US), SEIKAGAKU Corporation (Japan), Zimmer Biomet, Inc. (US), Smith & Nephew plc. (UK), Ferring Pharmaceutical B.V. (Switzerland), Lifecore Biomedical, LLC (US), LG Life Sciences Ltd. (South Korea), Fidia Farmaceutici S.p.A (Italy), F.Hoffmann-La Roche Ltd. (Switzerland).

Don’t miss out on business opportunities in Viscosupplementation Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com